Mettler-Toledo International Inc Stock Forecast for 2023 - 2025 - 2030
Updated on 09/26/2023
Mettler-Toledo International Inc Stock Forecast and Price Target
If Mettler-Toledo International Inc's stock price reached the average yearlong target of $1365.00 given by two well-known analysts in recent months, there would be a potential upside of approximately 23.51% from its last closing price in September, 2023. This potential increase is based on a high estimate of $1700.00 and a low estimate of $830.00. Even if you are not interested in MTD stock, you should still be aware of its competitors.
23.51% Upside
Mettler-Toledo International Inc Fair Value Forecast for 2023 - 2025 - 2030
Mettler-Toledo International Inc's Price has seen growth In the last two years, going from $819.49 to $1224.02 – a gain of 49.36% In the next year, analysts believe that Fair Value will reach $1519.50 – an increase of 24.14%. For the next eight years, the forecast is forFair Value to grow by 78.71%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| TMO Stock Forecast | Thermo Fisher Scientific Inc | Outperform |
10
|
$501.60 | $625.63 | 23.60% |
| DHR Stock Forecast | Danaher Corp | Outperform |
10
|
$247.25 | $304.24 | 23.15% |
| A Stock Forecast | Agilent Technologies | Outperform |
17
|
$110.73 | $141.56 | 50.37% |
| ILMN Stock Forecast | Illumina Inc | Outperform |
16
|
$128.91 | $254.08 | 93.55% |
| WAT Stock Forecast | Waters Corp | Hold |
15
|
$268.05 | $302.88 | 26.84% |
Mettler-Toledo International Inc Revenue Forecast for 2023 - 2025 - 2030
Mettler-Toledo International Inc's Revenue has seen growth In the last two years, going from $3.01B to $3.72B – a gain of 23.57% In the next year, analysts believe that Revenue will reach $4.18B – an increase of 12.46%. For the next eight years, the forecast is forRevenue to grow by 29.49%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| PKI Stock Forecast | PerkinElmer | Outperform |
16
|
$39.91 | $159.83 | 307.17% |
| AVTR Stock Forecast | Avantor | Buy |
16
|
$20.94 | $0.00 | 114.90% |
| BIO Stock Forecast | Bio-Rad Laboratories Inc | Buy |
16
|
$350.25 | $606.00 | 66.31% |
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| BRKR Stock Forecast | Bruker Corp | Outperform |
16
|
$61.34 | $72.11 | 22.27% |
| COHR Stock Forecast | Coherent | Hold |
12
|
$33.55 | $255.33 | 756.60% |
| PACB Stock Forecast | Pacific Biosciences of Califor... | Outperform |
9
|
$8.23 | $17.33 | 100.49% |
Mettler-Toledo International Inc Free Cash Flow Forecast for 2023 - 2025 - 2030
In the last two years, Mettler-Toledo International Inc's Free Cash Flow has increased by 58.32%, going from $506.11M to $801.25M. In the next year, analysts are expecting an increase in Free Cash Flow, predicting it will reach $942.25M – an increase of 17.60%. The Mettler-Toledo International Inc forecast is for Free Cash Flow to reach $1.06B or grow by 31.97%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| FLDM Stock Forecast | Fluidigm | - |
11
|
$20.37 | $12.00 | -91.31% |
| HBIO Stock Forecast | Harvard Bioscience | Buy |
14
|
$4.57 | $10.00 | 118.82% |
| EQTL Stock Forecast | Equitech International | - |
0
|
$2.00 | $0.00 | -100.00% |
Mettler-Toledo International Inc Net Income Forecast for 2023 - 2025 - 2030
Mettler-Toledo International Inc's Net Income has grown in the last two years, jumping from $561.11M to $768.99M – an increase of 37.05%. In the next year, analysts predict that Net Income will reach $941.60M – an increase of 22.45%. For the next eight years, the forecast is for Net Income to grow by 51.66%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| OMRX Stock Forecast | Orthometrix | - |
0
|
$0.00 | $0.00 | 0.00% |
| LFPI Stock Forecast | LifePoint | - |
0
|
$0.00 | $0.00 | 0.00% |
| MDIT Stock Forecast | Medite Cancer Diagnostics | - |
0
|
$0.00 | $0.00 | 0.00% |
Mettler-Toledo International Inc EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Mettler-Toledo International Inc's EBITDA has grown, increasing from $787.47M to $1.07B – an increase of 36.36%. For next year, the 7 analysts predict EBITDA of $1.31B, which would mean an increase of 22.18%. Over the next eight years, the pros' prediction is EBITDAof $1.53B, which would mean a eight-year growth forecast of 42.52%.
Mettler-Toledo International Inc EBIT Forecast for 2023 - 2025 - 2030
Mettler-Toledo International Inc's EBIT has increased by 37.23% In the last two years, going from $733.19M to $1.01B. In the next year, analysts expect EBIT to reach $1.25B – an increase of 24.02%. For the next eight years, the forecast is for EBIT to grow by 60.90%.
Mettler-Toledo International Inc EPS Price Prediction Forecast for 2023 - 2025 - 2030
Mettler-Toledo International Inc's EPS has seen growth In the last two years, going from $22.77 to $34.01 – a gain of 49.36% In the next year, analysts believe that EPS will reach $42.22 – an increase of 24.14%. For the next eight years, the forecast is forEPS to grow by 78.71%.